A 1-week direction of doxycycline is extra effective than single-dose azithromycin to treat rectal chlamydia in men who dangle intercourse with men (MSM), in conserving with newly published results in the Fresh England Journal of Remedy.
Chlamydia is the most recurrently reported bacterial sexually transmitted infection in the United States, with 4 million circumstances reported in 2018, and 127 million globally. Most infections are asymptomatic.
Charges of rectal chlamydia amongst MSM screened for infection fluctuate from 3% to 10.5%.
The most most up-to-date Facilities for Illness Alter and Prevention (CDC) chlamydia guidelines counsel either a single dose of azithromycin (1 gm) or doxycycline 100 mg twice day-to-day for 7 days. These 2015 guidelines had been in conserving with a meta-diagnosis of urogenital chlamydia infections, which showed connected efficacy of 97% or 98%, respectively.
Watch coauthor Jane S. Hocking, PhD, head of the Sexual Well being Unit on the University of Melbourne’s College of Population and Global Well being in Australia, knowledgeable Medscape Medical Info that “observational experiences had instructed that azithromycin became about 20% less effective than doxycycline,” prompting this clinical trial.
The perceive, conducted at five sexual health clinics in Australia, became a double-blind, randomized, controlled trial of doxycycline (100 mg twice day-to-day for 7 days) or azithromycin (1 gm single dose).
Due to 85% of contaminated men are asymptomatic, the perceive’s main final consequence became a unfavorable nucleic acid amplification test at 4 weeks, confirming a microbiologic cure.
The use of a modified draw-to-treat population, the perceive showed a microbiologic cure in 281 of 290 men (96.9%) in the doxycycline neighborhood and 227 of 297 (76.4%) in the azithromycin neighborhood (P < .001).
Negative occasions had been extra classic in the azithromycin neighborhood. Nausea, diarrhea, and vomiting occurred in 134 (45.1%) men in that neighborhood vs 98 men (33.8%) in these receiving doxycycline (P = .006).
A same perceive became reported in Clinical Infectious Ailments in February 2021 by Dombrowski et al. It became additionally randomized, double-blinded, and placebo-controlled nonetheless became smaller and conducted in Seattle and Boston. A 20% distinction became chanced on, with 80/88 (91%) in the doxycycline neighborhood and 63/89 (71%) in the azithromycin neighborhood having a microbiologic cure at 4 weeks of apply-up.
Jeanne Marrazzo, MD, director of the division of infectious ailments on the University of Alabama at Birmingham, knowledgeable Medscape Medical Info that the researchers targeted entirely on asymptomatic proctitis because “other symptoms also can imprint want for broader presumptive antibiotics” for coinfections. In the same vogue, symptomatic proctitis “also can imprint LGV [lymphogranuloma venereum] chlamydia, which…automatically mandates that 3-weeks of doxycycline be venerable.” Marrazzo concluded, “The indisputable truth that this became a blinded perceive obviously strengthens the conclusions/findings, which is immense. Or now no longer it’s very reassuring that results overall are so per the CID paper.” Marrazzo became now no longer all for either the Fresh England Journal of Remedy investigation or CID perceive.
Ina Park, MD, associate professor in the Division of Family and Neighborhood Remedy on the University of California San Francisco College of Remedy and author of Unusual Bedfellows: Adventures in the Science, History, and Gentle Secrets of STDs, became now no longer all for either perceive nonetheless has a protracted history of working with adolescents in clinics for sexually transmitted ailments. Per that journey, she knowledgeable Medscape Medical Info that while doxycycline now clearly appears to be to be the drug of alternative, “if compliance is a region and rectal chlamydia is now no longer seemingly, then I have confidence azithromycin is smooth something we’ve to expend into consideration, in particular for younger sufferers, and of us for whom compliance goes to be a region.” She added, “with adolescent sufferers, there are problems with fogeys per chance discovering the antibiotic and asking a entire lot questions. So, it’s very nice for fogeys to have the selection to accumulate therapy, vogue of a one and carried out manner in the clinic.”
The 2020 CDC Guidelines for Gonococcal Infections says, “CDC recommends a single 500 mg intramuscular dose of ceftriaxone for uncomplicated gonorrhea. Medication for coinfection with Chlamydia trachomatis with oral doxycycline (100 mg twice day-to-day for 7 days) must be administered when chlamydial infection has now no longer been excluded.”
Hocking concluded — and Marrazzo and Park concur — that this perceive “affords conclusive evidence that doxycycline must be the first-line cure for rectal chlamydia, nonetheless per chance for factual any chlamydia infection,” with particular exceptions.
The University of Melbourne researchers additionally noted that the doxycycline direction requires extra compliant sufferers, as adherence is now no longer assured. The grief of compliance and want for dependable now noticed therapy, hypersensitive response to doxycycline, and pregnancy (where doxycycline is contraindicated) will live the most essential indications for continued use of azithromycin.
N Engl J Med. Published online June 24, 2021. DOI: 10.1056/NEJMoa2031631. Summary
Hocking, Marrazzo, and Park reported no connected financial relationships.
For extra news, apply Medscape on Facebook, Twitter, Instagram, YouTube, and LinkedIn.
